Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The phase 2 trial followed participants for 48 weeks (nearly a year)
*Eligibility depends on CMS clinical criteria, your medical history, your body mass index (BMI), and other qualifying health conditions
2006;142C(2):7785
EMA refused 2017) [11]
You may qualify if: You have a Medicare Part D plan such as a: Medicare Advantage prescription drug (MAPD) plan: This is a Medicare Advantage plan that includes prescription drug coverage
Compared with Zytiga plus prednisone, the Akeega-based regimen significantly improved radiographic progression-free survival by 47% in BRCA-positive patients
US$ 20.33
US$ 19.99
US$ 27.86
US$ 25.89
US$ 28.48
US$ 24.47
